Lidocaine 0.05 MG/MG Medicated Patch [Lidocan] — RxCUI 2642344
RxNorm drug concept · Semantic branded drug
RxCUI 2642344
Semantic branded drug · SBD
● Current RxNorm concept 7 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2642344
Official nameLidocaine 0.05 MG/MG Medicated Patch [Lidocan]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLidocan 5 % Medicated Patch; Lidocan 0.05 MG/MG Medicated Patch
FDA products mapped7
Package NDCs mapped8
Reported Medicaid activity (SDUD)156 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
- What is this patch actually for — why did my doctor prescribe it?
- You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
- How long do I wear the patch, and can I wear more than one?
🕸️ Concept Web — How Lidocaine 0.05 MG/MG Medicated Patch [Lidocan] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine 0.05 MG/MG Medicated Patch [Lidocan]
RxCUI 2642344 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN
-
Lidocaine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lidocan
2642340BN
-
Lidocan
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine Medicated Patch
1792943SCDF -
Lidocaine Topical Product
1164666SCDG -
Lidocaine Medicated Patch [Lidocan]
2642343SBDF -
Lidocan Topical Product
2642342SBDG -
Medicated Patch
1792831DF -
Topical Product
1151122DFG
-
Lidocaine Medicated Patch
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine 0.05 MG/MG Medicated Patch
1745091SCD -
Lidocaine 0.05 MG/MG
332430SCDC -
Lidocaine 0.05 MG/MG [Lidocan]
2642341SBDC
-
Lidocaine 0.05 MG/MG Medicated Patch
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine 0.05 MG/MG Medicated Patch
SCD · 1745091 -
Lidocaine 0.05 MG/MG
SCDC · 332430 -
Lidocaine Medicated Patch
SCDF · 1792943 -
Lidocaine Topical Product
SCDG · 1164666
Brand-Name Concepts
-
Lidocaine 0.05 MG/MG [Lidocan]
SBDC · 2642341 -
Lidocaine Medicated Patch [Lidocan]
SBDF · 2642343 -
Lidocan Topical Product
SBDG · 2642342 -
Lidocan
BN · 2642340
📦 FDA Products & Package NDCs
7 products · 8 package NDCs
8 package NDCs map to RxCUI 2642344 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 59088-0731-00 | 1 KIT in 1 KIT (59088-731-00) * 30 POUCH in 1 PACKAGE (590... | Xyliderm | PureTek Corporation | 2023-07-05 |
| 59088-0900-54 | 30 POUCH in 1 PACKAGE (59088-900-54) / 14 g in 1 POUCH (590... | Lidocan VII | PURETEK CORPORATION | 2024-08-08 |
| 59088-0905-54 | 30 POUCH in 1 PACKAGE (59088-905-54) / 1 PATCH in 1 POUCH (... | Lidocan | PURETEK CORPORATION | 2023-07-14 |
| 59088-0905-82 | 15 POUCH in 1 PACKAGE (59088-905-82) / 1 PATCH in 1 POUCH (... | Lidocan | PURETEK CORPORATION | 2026-01-27 |
| 59088-0907-54 | 30 POUCH in 1 PACKAGE (59088-907-54) / 14 g in 1 POUCH (590... | Lidocan III | PURETEK CORPORATION | 2020-05-14 |
| 59088-0909-54 | 30 POUCH in 1 PACKAGE (59088-909-54) / 14 g in 1 POUCH (590... | Lidocan V | PURETEK CORPORATION | 2020-05-14 |
| 59088-0910-54 | 30 POUCH in 1 PACKAGE (59088-910-54) / 14 g in 1 POUCH (590... | Lidocan IV | PURETEK CORPORATION | 2023-06-15 |
| 59088-0911-54 | 30 POUCH in 1 PACKAGE (59088-911-54) / 14 g in 1 POUCH (590... | Lidocan VI | PURETEK CORPORATION | 2024-06-21 |
Observed labelers:
PURETEK CORPORATION (8)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.